Austin, Texas-based MDisrupt announced Monday that it has raised $5.7 million in seed funding to build its digital health intelligence platform, which will help accelerate the adoption of digital health tools. Investors in the seed round included AKESOgen co-founders Mark Bouzyk and Robert Boisjoli, Bren Investments, Chantell Preston, Grail co-founders Jessica Owens, Matthew Holt and Syrona Ventures, among others. The company declined to disclose the full list of investors.
Ruby Gadelrab, CEO and founder of MDisrupt, said that most digital health products often cannot be adopted in the healthcare system because payers and employers have no way to assess the effectiveness of the system.
MDisrupt addresses the lack of widespread adoption of digital health products with its data-driven platform, which allows digital health companies to generate datasets through clinical crowdsourcing, providing a way to evaluate existing systems. The idea, Gadelrab said, is that healthcare companies can show payers why they should cover their technology and why health systems should implement the technology, thereby driving providers to adopt the system.
“MDisrupt is transforming into a digital health intelligence company that organizes global digital health products by performance, so everyone (patients, consumers, providers, health systems, payerand employers) can make data-driven healthcare decisions,” Gadelrab said in an email.
According to Gadelrab, investment in digital health has exceeded $50 billion over the past two years. As such, she said there needs to be support for platforms, benchmarks and standards. As such, MDisrupt positions itself as a marketplace for companies in the digital health industry. If the company is successful, it can help the startup scale up. Gadelrab believes that overseas companies looking to commercialize in the U.S. can also benefit from the platform MDisrupt is trying to build.
“We are expanding our platform to enable digital health innovators to rapidly generate the real-world performance data needed to successfully commercialize and scale their products,” Gadelrab said. “An objective dataset built on the real clinical performance of each digital health product from the MDisrupt platform will inform the company’s digital health intelligence engine.”
MDiscrupt will use $5.7 million in seed funding to not only further develop its digital health intelligence platform, but also to build its product and engineAustin’s training team, according to Gadelrab.Additionally, the seed funding will help grow its commercial team as well as its community of health industry experts And the clinicians who will be early adopters of the technology.
“We’ve been constructing our cap table thoughtfully to diversify its design,” Gadelrab said. “We have a good balance of women, minorities, clinicians, health system executives and health industry experts.”
MDisrupt joins various efforts aimed at promoting technology adoption, such as, prove healthy, Highmark Health’s VITAL Innovation ProgramThere are a lot more.
Photo: Filograph, Getty Images
